KorMedi
  • Beauty
  • Health
  • Lifestyle
  • Medicine
  • Biowatch
  • Column
  • Kormedi.com TV
  • Notice
KorMedi
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Home  /  About the Reporter  /  Jonghyuck Won
원종혁 기자

Jonghyuck Won

Reporter
Biowatch Team I majored in medicine and have been covering the healthcare industry for 15 years. I will observe, listen, and report without bias.
mail every83@kormedi.com

Latest Articles

Is Your 'Focus Supplement' a Warning Sign? High Tyrosine Levels Linked to Shorter Lifespan in Men

3/2/2026

A Ray of Hope: ‘Low Expression’ Changes the Landscape of Breast Cancer Treatment

2/25/2026

DNA in Blood Speaks of Cancer Traces

2/12/2026

Can We Break Through Chemotherapy Resistance? A New Target for Triple-Negative Breast Cancer Appears

1/23/2026

NVIDIA and Eli Lilly Establish 'AI Drug Research Institute' with Up to $1.4 Trillion Investment Over 5 Years

1/13/2026

BMS Rare Heart Disease Drug 'Camzyos' Opens Prescription Path for Adolescents

1/13/2026

Next-Generation Precision Medicine for Cancer Treatment... Amgen Acquires UK Biotech for 1 Trillion Won

1/7/2026
Previous123
KorMedi
  • Business registration number: 214-87-97051
  • Press registration number: Seoul A 00292
  • Registration date: 2006-11-30
  • Title: Kormedi.com
  • Representative number: 02-2052-8200
  • Address: 7th floor, Seongwoo Building, 324 Toegye-ro, Jung-gu, Seoul
  • Issue date: November 30, 2006
  • Publisher and Editor-in-Chief: Seong Ju Lee
  • Youth Protection Officer: Simon Hong
  • Company Introduction
  • Privacy Policy
  • Terms of Service
  • Youth Protection Policy
  • Email Collection Refusal
  • Advisory Board
  • Advertising and Partnership Inquiries

Kormedi.com does not provide medical advice, diagnosis or treatment.

Multilingual content on this site is generated using AI-based translation and may contain errors or differences in interpretation. For legal or medical matters, please refer to the original language version.

© 2026 KoreaMedicare. All rights reserved.powered by Pango Lingo
Languages

ENGLISH

English (US)

ASIAN

日本語Tiếng ViệtBahasa Indonesia中文 (简体, 中国大陆)

EUROPEAN

РусскийEspañol (España)Français (France)

MIDDLE_EAST_AFRICA

العربية